Hi, what are you looking for?
Jewish Business News
Search results for "Mylan"
Court
– Teva sees the court preventing Mylan from launching its generic version of the Parkinson’s treatment before 2017. – Please help us out :...
Crime
The indictment investigation of the generic-drug industry has already resulted in more than 10 cases against companies and executives.
Court
Teva is currently diving 8.5% on high turnover in Tel Aviv Stock Exchange. Teva is completing a continuous plunge of more than 80% from...
Court
Teva significantly raised the price of 112 generic drugs and coordinated with more than a dozen companies. In some cases, prices increased by more...
Business
The CEO of Allergen tried to transfer ownership of the company's patents to Mohawk Indian tribe that enjoys legal immunity - but the court...
Life science
Teva shares rose 6% at the end of trading in New York after Berkshire Hathaway, the investment company controlled by Warren Buffett, revealed...
Court
The UK court ruled in favor of Mylan and its Dutch partner Synthon and canceled all of Teva's patents on Copaxone 40 mg in...
As many, world's richest hedge fund managers struggled in 2016 to keep up with U.S. financial market, but they still remain main players.
Mergers & Acquisitions
The pharmaceutical company's share price is up 9 percent after the report to TASE
Business
The generic drugmaker expects the new Israeli facility to generate $100 million in revenue annually.